Related posts

Feature

ENHANCED ABSORPTION: CurcumaSorb provides the patented Meriva curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability.*
JOINT SUPPORT: The efficacy of a low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva per day provided significant benefit in joint comfort, mobility and quality of life.*
OVERALL HEALTH: Provides support for musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.*
PURE INGREDIENTS: Pure Encapsulations manufactures a line of hypoallergenic, research-based dietary supplements. Products are meticulously formulated using pure ingredients designed to deliver predictable results for the benefit of all patients, even the most sensitive.*
FREE FROM: Pure Encapsulations products are free from wheat, gluten, egg, peanuts, magnesium stearate, hydrogenated fat, artificial sweeteners and colors, and other unnecessary excipients. Any product containing ingredients derived from allergens, such as soy, dairy or shellfish is clearly labeled.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Description

CurcumaSorb provides the patented Merivacurcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Merivathan standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg. Merivawere similar to values obtained from 4,000 mg. of a standard curcumin extract. The efficacy of a low dose was demonstrated in a 3-month clinical trial, in which 200 mg. curcuminoids from Merivaper day maintained healthy C-reactive protein levels and provided significant benefit in joint comfort, mobility and quality of life.*